Prediction of the time-course pattern of remission in depression by using clinical, neuropsychological, and genetic variables

Journal of Affective Disorders

Volumn 150, Issue 3, 2013, Pages 1082-1090

  Gudayol Ferre, Esteve ^a,b,c   Guardia Olmos, Joan ^e   Pero Cebollero, Maribel ^e   Herrera Guzman, Ixchel ^a,b,c   Camarena, Beatriz ^f   Cortes Penagos, Carlos ^a   Herrera Abarca, Jorge E ^a,c   Martinez Medina, Patricia ^d  

^a UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

^b Clinica de Enfermedades Crónicas Y de Procedimientos Especiales C E C Y P E   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d El Centro Michoacano de Salud Mental Morelia   (Mexico)

^e UNIVERSITY OF BARCELONA   (Spain)

^f Instituto National de Psiquiatria Ramon de la Fuente   (Mexico)

Author keywords

5HTTLPR; Antidepressant response; COMT; Major depressive disorder; Neuropsychological assessment; Polymorphism

Indexed keywords

CLONAZEPAM; FLUOXETINE;

5HTTLPR GENE; ALLELE; ARTICLE; CLINICAL ASSESSMENT; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; NEUROPSYCHOLOGY; PREDICTOR VARIABLE; PRIORITY JOURNAL; REMISSION; RS25531 GENE; SLC6A4 GENE; TREATMENT DURATION; TREATMENT RESPONSE;

5HTTLPR; ANTIDEPRESSANT RESPONSE; COMT; MAJOR DEPRESSIVE DISORDER; NEUROPSYCHOLOGICAL ASSESSMENT; POLYMORPHISM;

ADULT; ALLELES; AMINO ACID SUBSTITUTION; ANTIDEPRESSIVE AGENTS; CATECHOL O-METHYLTRANSFERASE; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUOXETINE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; REMISSION INDUCTION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TIME FACTORS; YOUNG ADULT;

EID: 84888369285     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.04.024     Document Type: Article

References (43)

1. Alexopoulos, G.S., Kiosses, D.N., Heo, M., Murphy, C.F., Shanmugham, B., Guning-Dixon, F., 2005. Executive Dysfunction and the course of geriatric depression. Biological Psychiatry 58, 204-210.
2. Alexopoulos, G.S., Gunning-Dixon, F.M., Latoussakis, V., Kanellopoulos, D., Murphy, C.F., 2008. Anterior cingulate dysfunction in geriatric depression. International Journal of Geriatric Psychiatry 23, 347-355.
3. Benedetti, F., Colombo, C., Pirovano, A., Marino, E., Smeraldi, E., 2009. The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting. Psychopharmacology 203, 155-160.
4. D'Aquila, P.S., Collu, M., Gessa, G.L., Serra, G., 2000. The role of dopamine in the mechanism of action of antidepressant drugs. European Journal of Pharmacology 405, 365-373.
5. Deutsch, A.Y., Roth, R.H., 2003. Neurotransmitters. In: Zigmond, F.J., Bloom, F.E., Landis, S.C., Roberts, J.L., Squire, L.R. (Eds.), Fundamental Neuroscience. Academic Press, San Diego, pp. 193-234.
6. Dunkin, J.J., Leuchter, A.F., Cook, I.A., Kasl-Godley, J.E., Abrams, R.N., Rosenberg-Thompson, S., 2000. Executive dysfunction predicts nonresponse to fluoxetine in major depression. Journal of Affective Disorders 60, 13-23.
7. Fava, G.A., Ruini, C., Rafanelli, C., Finos, L., Conti, S., Grandi, S., 2004. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. American Journal of Psychiatry 161, 1872-1876.
8. Friedman, E.S., Davis, L.L., Zisook, S., Wisniewski, S.R., Trivedi, M.H., Fava, M., Rush, A.J., 2012. CO-MED Study Team, 2012. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial. European Neuropsychopharmacology 22, 183-192.
9. Gartlehner, G., Gaynes, B.N., Hansen, R.A., Thieda, P., DeVeaugh-Geiss, A., Krebs, E.E., Moore, C.G., Morgan, L., Lohr, K.N., 2008. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Annals of Internal Medicine 149, 734-750.
10. Gorlyn, M., Keilp, J.G., Grunebaum, M.F., Taylor, B.P., Oquendo, M.A., Bruder, G.E., Stewart, J.W., Zalsman, G., Mann, J.J., 2008. Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects. Journal of Neural Transmission 115, 1213-1219.
11. Gudayol-Ferre, E., Herrera-Guzman, I., Camarena, B., Cortes-Penagos, C., Herrera-Abarca, J.E., Martinez-Medina, P., Cruz, D., Hernandez, S., Genis, A., Carrillo-Guerrero, M.Y., Aviles-Reyes, R., Guardia-Olmos, J., 2010. The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder. Journal of Affective Disorders 127, 343-351.
12. Gudayol-Ferre, E., Herrera-Guzman, I., Camarena, B., Cortes-Penagos, C., Herrera-Abarca, J.E., Martinez-Medina, P., Asbun-Bojalil, J., Lira-Islas, Y., Reyes-Ponce, C., Guardia-Olmos, J., 2012. Prediction of remission of depression with clinical variables, neuropsychological performance, and serotonergic/dopaminergic gene polymorphisms. Human Psychopharmacology 27, 577-586.
13. Hamilton, M., 1967. Development of a rating scale for primary depressive illness. British Journal of Social & Clinical Psychology 4, 278-296.
14. Heils, A., Teufel, A., Petri, S., Stober, G., Riederer, P., Bengel, D., Lesch, K.P., 1996. Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry 66, 2621-2624.
15. Henkel, V., Seemiiller, F., Obermeier, M., Adli, M., Bauer, M., Mundt, C., Brieger, P., Laux, G., Bender, W., Heuser, I., Zeiler, J., Gaebel, W., Mayr, A., Moller, H.J., Riedel, M., 2009. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. Journal of Affective Disorders 115, 439-449.
16. Henkel, V., Seemuller, F., Obermeier, M., Adli, M., Bauer, M., Kronmuller, K., Holsboer, F., Brieger, P., Laux, G., Bender, W., Heuser, I., Zeiler, J., Gaebel, W., Mayr, A., Riedel, M., Moller, H.J., 2011. Relationship between baseline severityof depression and antidepressant treatment outcome. Pharmacopsychiatry 44, 27-32.
17. Hirschfeld, R.M., Russell, J.M., Delgado, P.L., Fawcett, J., Friedman, R.A., Harrison, W.M., Koran, L.M., Miller, I.W., Thase, M.E., Howland, R.H., Connolly, M.A., Miceli, R.J., 1998. Predictors of response to acute treatment of chronic and doubledepression with sertraline or mipramine. Journal of Clinical Psychiatry 59, 669-675.
18. Husain, M, M., Rush, A.J., Fink, M., Knapp, R., Petrides, G., Rummans, T., Biggs, M.M., O'Connor, K., Rasmussen, K., Litle, M., Zhao, W., Bernstein, H.J., Smith, G., Mueller, M., McClintock, S.M., Bailine, S.H., Kellner, C.H., 2004. Speed of response and remission in major depressive disorder with acute electrocon-vulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. Journal of Clinical Psychiatry 161, 1872-1876.
19. Judd, L.L., Akiskal, H.S., Zeller, P.J., Paulus, M., Leon, A.C., Maser, J.D., Endicott, J., Coryell, W., Kunovac, J.L., Mueller, T.I., Rice, J.P., Keller, M.B., 2000a. Psychosocial disability during the long-term course of unipolar major depressive disorder. Archives of General Psychiatry 57, 375-380.
20. Judd, L.L., Paulus, M.J., Schettler, P.J., Akiskal, H.S., Endicott, J., Leon, A.C., Maser, J.D., Mueller, T., Solomon, D.A., Keller, M.B., 2000b. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? American Journal of Psychiatry 157, 1501-1504.
21. Kemp, A.H., Gordon, E., Rush, J., Leanne, M., Williams, M., 2008. Improving the prediction of treatment response in depression: Integration of clinical, cognitive, psychophysiological, neuroimaging and genetic measures. CNS Spectrums 13, 1066-1086.
22. Keller, M.B., 2004. Remission versus response: the new gold standard of anti-depressant care. Journal of Clinical Psychiatry 65 (Suppl. 4), 53-59.
23. Kim, J.M., Kim, S.Y., Stewart, R., Yoo, J.A., Bae, K.Y., Jung, S.W., Lee, M.S., Yim, H.W., Jun, T.Y., 2011. Improvement within 2 weeks and later treatment outcomes in patients with depressive disorders: the CRESCEND study. Journal of Affective Disorders 129, 183-190.
24. Kleimbaun, D.G., 1994. Logistic Regression. A self-learning Text. Springer-Verlag, Inc., New York.
25. Kobayashi, K., Haneda, E., Higuchi, M., Suhara, T., Suzuki, H., 2012. Chronic fluoxetine selectively upregulates dopamine D1-like receptors in the hippocampus. Neuropsychopharmacology 37, 1500-1508.
26. Koenig, H, G., Johnson, J.L., Peterson, B.L., 2006. Major depression and physical illness trajectories in heart failure and pulmonary disease. Journal of Nervous and Mental Disease 194, 909-916.
27. Lezak, M.D., Howiesson, D.B., Loring, D.W., 2004. Neuropsychological Assessment, fourth ed. Oxford University Press, Oxford.
28. Morimoto, S.S., Gunning, F.M., Kanellopoulos, D., Murphy, C.F., Klimstra, S.A., Kelly Jr., R.E., Alexopoulos, GS., 2012. Semantic organizational strategy predicts verbal memory and remission rate of geriatric depression. International Journal of Geriatric Psychiatry 27, 506-512.
29. Nebes, R.D., Butters, M.A., Mulsant, B.H., et al., 2000. Decreased working memory and processing speed mediate cognitive impairment in geriatric depression. Psychological Medicine 30, 679-691.
30. Reynolds 3rd, C.F., Dew, M.A., Frank, E., Begley, A.E., Miller, M.D., Cornes, C., Mazumdar, S., Perel, J.M., Kupfer, D.J., 1998. Effects of age at onset of first lifetime episode of recurrent major depression on treatment response and illness course in elderly patients. American Journal of Psychiatry 155, 795-799.
31. Robbins, T.W., James, M., Owen, A.M., Sahakian, B.J., McIness, L., Rabitt, P., 1994. Cambridge neuropsychological test automated battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 5, 266-281.
32. Searle, k., 1992. General Linear Models. Wiley and Sons, New York.
33. Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., Dunbar, G.C., 1998. The mini-international neuropsy-chiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59 (Suppl 20), 22-33.
34. Spronk, D., Arns, M., Barnett, K.J., Cooper, N.J., Gordon, E., 2011. An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study. Journal of Affective Disorders 128, 41-8.
35. Stassen, H.H., Angst, J., Hell, D., Scharfetter, C., Szegedi, A., 2007. Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients. Journal of Clinical Psychiatry 68, 1195-1205.
36. Szadoczky, E., Rozsa, S., Zambori, J., Furedi, J., 2004. Predictors for 2-year outcome of major depressive episode. Journal of Affective Disorders 83, 49-57.
37. Szegedi, A., Rujescu, D., Tadic, A., Muller, M.J., Kohnen, R., Stassen, H.H., Dahmen, N., 2005. The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. Pharmacogenomics Journal 5, 49-53.
38. Szegedi, A., Jansen, W.T., Van Willigenburg, A.P., van der Meulen, E., Stassen, H.H., Thase, M.E., 2009. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. Journal of Clinical Psychiatry 70, 344-353.
39. Tadic, A., Helmreich, I, Mergl, R., Hautzinger, M., Kohnen, R., Henkel, V., Hegerl, U., 2010. Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression. Journal of Affective Disorders 120, 86-93.
40. Tsai, S.J., Gau, Y.T., Hong, C.J., Liou, Y.J., Yu, Y.W., Chen, T.J., 2009. Sexually dimorphic effect of catecol-O-methyltransferase val 158 met polymorphism on clinical response to fluoxetine in major depressive patients. Journal of Affective Disorders 113, 183-187.
41. Thase, M.E., Rush, A.J., 1995. Treatment-resistant depression. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation Progress. New York Raven Pres, pp. 1081-1098.
42. Taylor, B.P., Bruder, G.E., Stewart, J.W., McGrath, P.J., Halperin, J., Ehrlichman, H., Quitkin, F.M., 2006. Psychomotor slowing as a predictor of fluoxetine non-response in depressed outpatients. American Journal of Psychiatry 163, 73-78.
43. Warden, D., Rush, A.J., Trivedi, M.H., Fava, M., Wisniewski, S.R., 2007. The STAR.*D Project results: a comprehensive review of findings. Current Psychiatry Reports 6, 449-459.